Business Model Breakdown
How Intuitive Surgical Inc Makes Money
ISRG
Market Cap
$166.6B
Annual Revenue
$10.1B
Profit Margin
28.4%
Employees
15,638
The Short Version
Intuitive Surgical generates revenue primarily by providing robotic-assisted surgical systems, most notably the da Vinci platform, to hospitals and surgical centers globally. Its business model resembles a 'razor-and-blade' approach: initial sales of the expensive da Vinci systems are followed by high-margin, recurring revenue from the disposable instruments and accessories used in each surgery, as well as ongoing service contracts and training. This creates a deeply embedded ecosystem where the initial capital outlay is continually monetized through subsequent procedure volumes.
Where the Revenue Comes From
Instruments & Accessories (~55% of total revenue based on Q1 2026 estimates)
Systems (~22% of total revenue based on Q1 2026 estimates)
Services (~16% of total revenue based on Q1 2026 estimates)
Who buys: Hospitals, surgical centers, and other healthcare providers worldwide.
Why It Works (Competitive Advantages)
- ✔Extensive installed base and surgeon training ecosystem creating significant switching costs.
- ✔Strong intellectual property portfolio and continuous R&D investment.
- ✔High gross margins from recurring instrument and service revenue.
- ✔Established brand recognition and trust within the surgical community.
Economic Moat: Wide (Switching Costs, Intangible Assets/IP, Efficient Scale)
What Our Analysis Says
DVR Score as of April 20, 2026
Intuitive Surgical (ISRG) continues to demonstrate strong operational performance, evidenced by its Q4 2025 revenue growth of 18.8% YoY and robust EPS beat. It maintains its undisputed leadership in robotic-assisted surgery, supported by a growing installed base of 11,423 da Vinci systems and impressive Ion system adoption. The company's formidable moat, built on IP, high switching costs, and extensive R&D, ensures durable future growth within its expanding market. However, the premise of achieving a 10x return ($1.66 trillion valuation) within 3-5 years for a company of its current $166.65 billion market cap remains extraordinarily improbable. While a premier long-term compounder, its established large-cap status fundamentally limits multi-bagger potential within the aggressive timeframe, a view consistent with previous assessments. Recent product recalls, cybersecurity reports, and tariff headwinds introduce minor operational risks, partially offset by solid financial execution, thus maintaining the low 10x potential score.